CVS Health Corporation [NYSE: CVS] loss -0.94% on the last trading session, reaching $75.56 price per share at the time. The company report on February 8, 2023 that CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2022 RESULTS.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2022.
CVS Health Corporation represents 1.31 billion in outstanding shares, while the company has a total market value of $96.90 billion with the latest information. CVS stock price has been found in the range of $74.7921 to $76.89.
If compared to the average trading volume of 8.83M shares, CVS reached a trading volume of 8170245 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about CVS Health Corporation [CVS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $113.52 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as In-line, with their previous recommendation back on January 03, 2023. While these analysts kept the previous recommendation, Morgan Stanley dropped their target price from $124 to $119. The new note on the price target was released on November 23, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $120, while Loop Capital analysts kept a Buy rating on CVS stock. On May 27, 2022, analysts decreased their price target for CVS shares from 122 to 112.
The Average True Range (ATR) for CVS Health Corporation is set at 1.65, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.30. The Price to Book ratio for the last quarter was 1.39, with the Price to Cash per share for the same quarter was set at 12.26. Price to Free Cash Flow for CVS in the course of the last twelve months was 9.19 with Quick ratio for the last quarter at 0.70.
Trading performance analysis for CVS stock
CVS Health Corporation [CVS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.08. With this latest performance, CVS shares dropped by -15.73% in over the last four-week period, additionally sinking by -26.67% over the last 6 months – not to mention a drop of -26.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 19.89, with the RSI for the last a single of trading hit 14.97, and the three-weeks RSI is set at 24.03 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 86.52, while it was recorded at 77.15 for the last single week of trading, and 94.47 for the last 200 days.
CVS Health Corporation [CVS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.08 and a Gross Margin at +16.92. CVS Health Corporation’s Net Margin is presently recorded at +1.29.
Return on Equity for this stock inclined to 5.68, with Return on Assets sitting at 1.74.
CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.
CVS Health Corporation [CVS]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 5.71%.
An analysis of insider ownership at CVS Health Corporation [CVS]
There are presently around $78,526 million, or 80.70% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 117,533,372, which is approximately 1.379% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 94,974,082 shares of the stock with an approximate value of $7.18 billion in CVS stocks shares; and STATE STREET CORP, currently with $4.37 billion in CVS stock with ownership of nearly -0.798% of the company’s market capitalization.
Positions in CVS Health Corporation stocks held by institutional investors increased at the end of Wednesday and at the time of the Wednesday reporting period, where 1,184 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 44,058,375 shares. Additionally, 1,129 investors decreased positions by around 42,747,114 shares, while 231 investors held positions by with 952,443,205 shares. The mentioned changes placed institutional holdings at 1,039,248,694 shares, according to the latest SEC report filing. CVS stock had 218 new institutional investments in for a total of 5,684,696 shares, while 117 institutional investors sold positions of 3,131,475 shares during the same period.